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Reversible protein biotinylation is readily aﬀected via conjugation
with a bromomaleimide-based reagent followed by reductive
cleavage. The intermediate biotinylated protein constructs are
stable at physiological temperature and pH 8.0. Quantitative
reversibility is elegantly delivered under mild conditions of using
a stoichiometric amount of a bis-thiol, thus providing an approach
that will be of general interest in chemical biology and
proteomics.
To facilitate the study of a plethora of complex biological pro-
cesses, robust methods for the selective enrichment of tagged
proteins from complex biological mixtures is of primary
importance. Use of the biotin–avidin interaction, to facilitate
biotin-labeled protein enrichment or immobilisation, is a well-
established technique.1–3 However, classical approaches based
on this method are limited in that in order to ultimately
retrieve the protein of interest the very strong biotin–avidin
interaction (Ka = 1.7 × 10
15 M−1) must be disrupted. This is
often achieved under harsh, denaturing conditions that are
not experimentally useful.1 Strategies have been developed to
try and address this problem. The first approach requires the
design of analogues of biotin which bind with lower aﬃnity to
avidin.4 Although useful, this approach is inherently hampered
as increased ease of elution comes at the price of weaker
initial binding. A second approach is to design aﬃnity probes
which maintain the native biotin–avidin interaction but which
incorporate a cleavable linker.1,2
We have recently reported a new approach to cysteine bio-
conjugation through the use of bromomaleimides and bromo-
pyridazinediones.5 To date, our approach has provided access
to complex bioconjugates in high yields, without prior acti-
vation of reagents. As part of this programme, we reported a
new bromomaleimide-based aﬃnity-tagging reagent which
allows for the facile and reversible biotinylation of proteins.5c
A buﬀered solution of a single point mutant (L111C) of the
SH2 domain of the Grb2 adapter protein was aﬃnity-tagged,
and incubated, prior to cleavage in a large excess of beta-
mercaptoethanol (BME, 100 equivalents, 25 mM). Although we
have found this protocol to be useful, we discovered that pro-
longed incubation of the aﬃnity-tagged protein lead to some
unwanted maleimide hydrolysis (ca. 40% hydrolysis at 37 °C
after 4 h at pH 8.0) which rendered the labeling, at least par-
tially, irreversible, resulting in a sub-optimal yield of recovered
protein. Furthermore, the relatively harsh cleavage conditions
are unlikely to be compatible with proteins that contain sen-
sitive disulfide bonds, potentially resulting in unfavourable
protein unfolding, aggregation or disulfide scrambling. This
limitation is particularly important when one considers that
disulfide bonds are often very important for the structural
stability of proteins.6
We report herein a novel aﬃnity tag reagent, which yields
bioconjugates that are stable to maleimide hydrolysis over
extended periods of time at physiological temperature and pH
8.0. Furthermore, we describe the subsequent liberation of
native protein from the bioconjugate under mild conditions, a
single equivalent of a dithiol, in both a model system and in
proof of concept biotin–streptavidin pull-down experiments.
The nature of the N-substituent of a maleimide is known to
eﬀect the rate of hydrolysis to the corresponding maleamic
acid.7 Indeed, we have recently described the exploitation of
this eﬀect for the irreversible labelling of proteins with hydro-
lytically unstable maleimides bearing electron withdrawing
groups on nitrogen, such as N-phenylmaleimides.5c Given that
electron withdrawing substituents on the maleimide nitrogen
promote hydrolysis,5c,7 we envisaged that incorporation of an
electron donating substituent on the maleimide nitrogen
would suppress such an eﬀect.
Thus, n-butyl and methoxy substituents (inductively and
mesomerically electron donating groups, respectively), were
incorporated into bromomaleimides to form compounds 1
and 2 for model hydrolysis studies. We also synthesised
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ethylglycol methyl ether bromomaleimide 3 to investigate
whether the hydrolysis of our previously reported PEG-biotin
linker was intimately linked to the ethyl glycol ether function-
ality. Cyclohexylmethyl bromomaleimide 4 was also syn-
thesised to assess whether a N-cyclohexylmethyl group, as in
the case reported by Hermanson,8 would reduce hydrolysis in
this system. Bromomaleimides 1–4 were readily synthesised by
refluxing bromomaleic anhydride with the corresponding
amine in acetic acid for 3 h. The crude reaction was purified
by column chromatography to yield pure bromomaleimides
1–4 with yields ranging from 54% to 72% (see ESI† for details).
Single point mutant (L111C) of the SH2 domain of Grb2
adaptor protein, 5, which otherwise does not contain cysteine
residues, was chosen as a model protein. This protein was
treated with one equivalent of bromomaleimide reagent for
1 h at 0 °C (these bioconjugation reactions may also be per-
formed at room temperature or 37 °C). Analysis of the crude
reaction mixtures by LCMS indicated that, despite varying the
N-substituent, reactions with bromomaleimides 1–4 proceeded
with quantitative conversion. The hydrolytic stability of the
conjugates was then assessed by incubation at 37 °C for 4 h at
pH 8.0 (Table 1). Although the conjugates of bromomaleimides
2 and 3 showed significant hydrolysis, the conjugates of 1 and
4 were completely stable. On this basis, it was concluded that a
non-functionalised alkyl chain (i.e. an inductively electron
donating group) on the maleimide nitrogen should be
suﬃcient to minimise hydrolysis.
In light of the results with bromomaleimides 1 and 4, a bio-
tinylated-bromomaleimide derivative with a non-functionalised
alkyl chain, dodecane-biotin bromomaleimide 6, was syn-
thesized and its hydrolytic stability evaluated. Decane-1,10-
diamine, rather than butyl-1,4-diamine or 4-(aminomethyl)-
cyclohexanamine, was chosen as the spacer to minimise any
interference between the protein and the biotin–streptavidin
interaction. Bromomaleimide 6 was synthesized by coupling
mono Boc protected decane-1,10-diamine with activated biotin,
followed by TFA deprotection of the Boc group and reaction
with bromomaleic anhydride in acetic acid (see ESI† for details).
The reactivity of biotinylated bromomaleimide 6 with Grb2
SH2 (L111C) 5 was tested and, as anticipated, reaction at 0 °C
for 1 h resulted in the formation of bioconjugate 8 in quanti-
tative conversion (Scheme 1). In order to evaluate whether the
eﬃciency of bioconjugation with bromomaleimide 6 was
specific to Grb2 SH2 (L111C) 5, reaction was also carried out
with GFP (S147C) 7.5b Use of a fluorescent protein would also
provide a parameter by which to quantify the release of protein
in our reversible biotinylation methodology (vide infra). Gratify-
ingly, bioconjugation with GFP (S147C) 7 also proceeded
eﬃciently, forming bioconjugate 9 in quantitative conversion
(Scheme 1). Conjugates 8 and 9 were then tested for stability
by heating them at 37 °C, pH 8.0 for 4 h. Most pleasingly, as
observed with the n-butyl and cyclohexylmethyl model
systems, no hydrolysis was observed.‡
Having established that adducts 8 and 9 are stable to
hydrolysis at physiological temperature at pH 8.0 over a pro-
longed period of time, and in view of our goal of providing a
general protocol for the reversible biotinylation of proteins, we
Table 1 Reaction of Grb2 SH2 (L111C) 5 with bromomaleimides 1–4 and sta-











aDetailed experimental details are given in the ESI.
Scheme 1 Reaction of dodecane-biotin bromomaleimide 6 with Grb2 SH2
(L111C) 5 and GFP (S147C) 7, and release of the free proteins using BME (100×)
or EDT (1×).
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turned our attention to developing a mild set of cleavage con-
ditions for the liberation of a protein of interest from the aﬃnity
label. In our previous report, we described that Grb2 SH2
(L111C) maleimide conjugates react with a single equivalent of
thiol to form bisthioethers.5a,c In an environment of an excess of
thiol, however, these bioconjugate thioethers are unstable, indi-
cating that the process is under equilibrium (Scheme 2(a)). To
date, this reversibility has been exploited by adding a large
excess of thiol (i.e. 100× of BME or Glutathione) to facilitate the
release of free protein. However, a major disadvantage of this
technique is that it requires a large excess of thiol, which, as dis-
cussed above, could limit the applicability of this approach.
To improve upon our capture and release methodology, it
was essential to facilitate the release of free protein without
using an excess of thiol (Scheme 2(a)). We rationalised that
dithiosuccinimides are unlikely to be stable because of the low
pKa of the succinimide proton – and that this is key for the
reversibility of this system. We envisaged that a tether-type
approach using bidentate thiol nucleophiles which could form
bi- or spirocyclic adducts by trapping the reactive dithio-
succinimides into a stable, unreactive adduct, would liberate
free protein without the need for an excess of thiol. Thus, we
embarked upon a model study using thiomaleimide 10. Pleas-
ingly, reaction of 10 with a single equivalent of 1,2-ethane-
dithiol (EDT) aﬀorded spirocyclic dithiane 11 in 95% yield
after 24 h (Scheme 2(b)). Further insight into the mechanism
of cleavage of thiomaleimide with ethanedithiol was provided
by treatment of N-methylbromomaleimide with EDT, which
revealed the formation of two major products, spirocyclic
dithiane 11 and bicyclic bisthioether 12 in a 65 : 35 ratio after
90 min at 37 °C (Scheme 2(c)). However, after prolonged incu-
bation at 37 °C, bicyclic bisthioether 12 was completely con-
verted to the thermodynamic product, dithiane adduct 11.
The EDT cleavage strategy was evaluated by incubation of
biotin–bromomaleimide conjugates 8 and 9 with a single
equivalent of EDT for 4 h at 37 °C, pH 8.0. Analysis of the
crude reaction mixtures by LCMS revealed complete regene-
ration of free unmodified proteins with no evidence for the sig-
nificant formation of side-products (Scheme 1).‡ As a control,
our previously reported cleavage conditions were also applied
to biotinylated conjugates 8 and 9.5c Although reaction of 9
with excess BME (100 equivalents) for 4 h at 37 °C, pH 8.0
yielded GFP (S147C) 7 in quantitative conversion, sub-optimal
yield (ca. 90%) was observed for release of Grb2 SH2 (L111C) 5
from adduct 8 as a result of the persistence of succinimide
formed from mono-addition of BME to 8; thus highlighting a
further advantage of our novel dithiol cleavage strategy.
Having identified an aﬃnity tag which is stable to hydro-
lysis at 37 °C for several hours and a reagent which enables
clean release of protein with only a single equivalent of redu-
cing thiol (EDT), we sought to evaluate these optimised proto-
cols in proof of concept pull down experiments (Scheme 3).
This also provided an opportunity to compare our pre-
viously reported PEG maleimide reagent5c with our new
decane bromomaleimide reagent 6. Thus, GFP (S147C) 7 was
modified with PEG and decane maleimide reagents at 0 °C for
1 h, forming bioconjugates 13 and 9 in quantitative conver-
sion. Bioconjugates 13 and 9 were then incubated directly with
streptavidin beads at 37 °C for 4 h (Scheme 3(a)). In each case,
after the incubation period, unbound GFP-bioconjugate
was removed by washing the beads with PBS buﬀer solution
(3 × 10-fold dilution). Incubation of the washed GFP (S147C)
loaded streptavidin beads (14 and 15) with EDT at 37 °C for
4 h resulted in release of GFP (S147C) 7 (Scheme 3(a)); this was
determined by fluorescence analysis (vide supra) of the super-
natant (Scheme 3(b)). Gratifyingly, a significantly increased
level of release from the decane conjugate 9 was observed,
likely due to superior hydrolytic stability. This clearly demon-
strates a substantial advantage of 6 over our previously
reported PEG linked aﬃnity tag reagent and the applicability
of our mild cleavage conditions to reversible protein aﬃnity
labelling using streptavidin beads; thus highlighting the
potential of our optimised cleavable tag/EDT strategy.
Conclusions
The continuing study of the interaction of proteins with other
biomolecules is vital in furthering our understanding of
human physiology. The development of proteomic techno-
logies will facilitate the discovery of new diagnostics and drugs
that will underpin 21st century medicine.9,10 Key to this is the
development of novel conjugation technologies that allow for
the enrichment, manipulation and analysis of proteins using
mild conditions that are compatible with maintaining native
Scheme 2 (a) Reaction of Grb2 SH2 (L111C) maleimide bioconjugate with
an excess of thiol; (b) Reaction of cysteine–maleimide conjugate with EDT;
(c) Reaction of N-methylbromomaleimide with EDT, and rearrangement of 12 to 11.
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protein structure and function.11 We have described an
elegant approach that enables the reversible aﬃnity-labelling
of proteins. We envisage that this technology will have appli-
cations in a variety of aﬃnity applications but particularly in
proteomic applications where the capture, release and analysis
of native proteins and their complexes is highly desirable.
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